ZINDACLIN

This brand name is authorized in Austria, Spain, Hong Kong, Ireland, Israel, Singapore, Turkey, United Kingdom

Active ingredients

The drug ZINDACLIN contains one active pharmaceutical ingredient (API):

1 Clindamycin UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. Read about Clindamycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZINDACLIN Gel	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D10AF01	Clindamycin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 66610
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 38170
Country: HK	Department of Health Drug Office	Identifier(s): 53655
Country: IE	Health Products Regulatory Authority	Identifier(s): 59816
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4695
Country: SG	Health Sciences Authority	Identifier(s): 13157P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8697757341016